Changeflow GovPing Pharma & Drug Safety Dual Target Binding Peptide Composition for Act...
Routine Notice Added Draft

Dual Target Binding Peptide Composition for Active Targeting DDS

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260092084A1 by MESCUE-JANUSYS INC. for a dual target-binding peptide composition with hydrophilic and hydrophobic regions for active targeting drug delivery systems. The application (No. 18876803) was filed June 23, 2023 and published April 2, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260092084A1 for a peptide composition designed for dual target binding. The peptide includes a hydrophobic region and a hydrophilic region positioned on at least one end of the hydrophobic region, with the hydrophilic region having lower hydrophobicity. The composition features a first target binding site at one end and a second target binding site at the other end. The technology is classified under C07K 14/00, C07K 7/08, and A61K 38/00.

This publication establishes prior art for entities developing similar peptide-based drug delivery systems. Inventors are Mitsunori HARADA and Chuya YOSHIDA. Patent applicants and researchers in the pharmaceutical/biotechnology space should review this application to assess potential conflicts with their own IP portfolios.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PEPTIDE AND ASSEMBLY OR COMPOSITION CONTAINING SAID PEPTIDE

Application US20260092084A1 Kind: A1 Apr 02, 2026

Assignee

MESCUE-JANUSYS INC.

Inventors

Mitsunori HARADA, Chuya YOSHIDA

Abstract

A peptide or a derivative thereof or a salt thereof, including a hydrophobic region, and a hydrophilic region positioned on at least one end side of the hydrophobic region and having hydrophobicity lower than that of the hydrophobic region, including, at one end, a first target binding site capable of binding to a first target, and including, at the other end, a second target binding site capable of binding to a second target. The peptide is applicable to an active targeting DDS.

CPC Classifications

C07K 14/00 C07K 7/08 A61K 38/00

Filing Date

2023-06-23

Application No.

18876803

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260092084A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!